featured
2022 Top Story in Diabetes: EMPA-KIDNEY
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease N Engl J Med. 2020; 383(15):1436-1446.
- The EMPA-KIDNEY Collaborative Group. Empagliflozin in Patients With Chronic Kidney Disease. N Engl J Med. 2022 Nov 4. DOI: 10.1056/NEJMoa2204233. Online ahead of print.
Disclosure statements are available on the authors' profiles: